Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -5.02% | -9.66% | 6.85% | 7.71% | -11.47% |
Total Depreciation and Amortization | 7.55% | -5.44% | 169.34% | -206.00% | -5.44% |
Total Amortization of Deferred Charges | 18.18% | 0.00% | -98.64% | -53.15% | 10,718.75% |
Total Other Non-Cash Items | 9.90% | 6.90% | -5.96% | -6.92% | -0.50% |
Change in Net Operating Assets | 197.57% | -706.21% | -4.36% | -37.12% | 128.34% |
Cash from Operations | 70.44% | -96.46% | 7.07% | -25.51% | 51.08% |
Capital Expenditure | 83.72% | -171.17% | 73.32% | 11.30% | -3.99% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -66.78% | 17.18% | 97.82% | 2,058.20% | 82.20% |
Cash from Investing | -66.46% | 15.97% | 108.37% | 908.50% | 66.69% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | 100.00% | -- |
Issuance of Common Stock | -95.78% | 498.20% | -75.82% | 1,812.50% | -97.22% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -110.09% | 970.97% | -86.49% | 2,186.36% | -102.55% |
Foreign Exchange rate Adjustments | -455.24% | -154.40% | 262.18% | -158.70% | -195.83% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -74.99% | -51.92% | 5,127.81% | 97.74% | 50.16% |